ID: ALA5282459

Max Phase: Preclinical

Molecular Formula: C13H11NOS

Molecular Weight: 229.30

Associated Items:

Representations

Canonical SMILES:  N#CSCCOc1cccc2ccccc12

Standard InChI:  InChI=1S/C13H11NOS/c14-10-16-9-8-15-13-7-3-5-11-4-1-2-6-12(11)13/h1-7H,8-9H2

Standard InChI Key:  MMGIUGWQAWAMFC-UHFFFAOYSA-N

Associated Targets(non-human)

Toxoplasma gondii 4585 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vero 26788 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 229.30Molecular Weight (Monoisotopic): 229.0561AlogP: 3.43#Rotatable Bonds: 4
Polar Surface Area: 33.02Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.27CX LogD: 3.27
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.59Np Likeness Score: -0.84

References

1. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X..  (2021)  Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations.,  64  (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569]

Source